pocketful logo light
pocketful logo light
Kimia Biosciences Ltd logo

Kimia Biosciences Ltd

NSE: BSE: 530313

27.92

(2.72%)

Tue, 25 Aug 2026, 09:19 am

Kimia Biosciences Share Price Live Chart

1 Day

(2.72%)

No Result Found

Summary

  • Market Cap (in Cr)

    172.69

  • Net Profit (in Cr)

    9.61

  • P/B

    20.15

  • Sector P/E

    44.89

  • P/E

    20.94

  • EV/EBITDA

    10.82

  • Debt/Equity (Industry)

    0.17

  • Interest Cover (Industry)

    18.17

  • ROCE (Industry)

    20.59

  • RONW (Industry)

    17.62

  • ROE

    172.53

  • ROCE

    34.57

  • Debt/Equity

    7.46

  • EPS (TTM)

    1.91

  • Dividend Yield

    0

  • Book Value

    2.45

  • Interest Cover

    3.99

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters74.9474.9474.9474.9474.94
FII00000
DII0.380.380.380.380.38
Public24.6824.6824.6824.6824.68
Government00000

Read More

Technical Analysis

RSI

39.13

MACD

-1.14

50 DMA

31.06

200 DMA

32.18

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic42.2937.3034.6132.3129.6227.3222.33
Fibonacci37.3035.3934.2132.3130.4029.2227.32
Camarilla33.3032.8432.3932.3131.4731.0230.56

Pivots Level: Classic

R3

+9.98

42.29

R2

+4.99

37.30

R1

+2.31

34.61

32.31
32.31
Pivot Point
LTP: 27.26

S1

-2.68

29.62

S2

-4.99

27.32

S3

-9.98

22.33

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    28.16

  • 20-EMA

    29.03

  • 30-EMA

    29.74

  • 50-EMA

    30.71

  • 100-EMA

    31.87

  • 200-EMA

    33.73

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 May 2026board-meetingsAccounts
14 Feb 2026board-meetingsQuarterly Results, Nine Months Results
14 Nov 2025board-meetingsQuarterly Results
29 Aug 2025agm
25 Jun 2025egm
05 Dec 2024agm
02 Sept 2023agm
23 Sept 2022agm
28 Aug 2021agm

Read More

Peer Comparison

Kimia Biosciences Ltd logo

Kimia Biosciences Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Kimia Biosciences Ltd About

Kimia Biosciences main objective of the Company is to carry on business of Pharamaceutical products.

Industry

Pharmaceuticals - Indian - Bulk Drugs

Founded

1993

Headquarters

CEO

Sameer Goel

Employees

Contact

Website icon

Website

http://www.kimiabiosciences.com

Email icon

Email

compliance.kimia@gmail.com

Phone icon

Phone

91-11-29535650

Location icon

Location

Bhondsi Village, Tehsil Sohna, Gurgaon, Haryana, 122102

Read More

Kimia Biosciences Ltd Company History

YearHistory
1993
  • Laurel Organics Ltd. was incorporated in district Gurgaon, Haryana, India.
2017
  • NCLT approved the Scheme of Arrangement for Amalgamation of Kimia Biosciences Limited with Laurel Organics Limited
2019
  • The company name was changed to Kimia Biosciences Ltd. from Laurel Organics Ltd.
2024
  • Kimia Biosciences Limited was awarded a contract by a European client worth USD 200,000.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
No Result Found

Read More

Kimia Biosciences Ltd News

Kimia Biosciences FY26 net profit falls 22.7%

Kimia Biosciences reported a 22.7% decline in net profit to ₹743.37 lakh for FY26. Revenue from operations decreased to ₹11,488.38 lakh.

29 May 2026

companies

Kimia Biosciences Board Meet on May 29

Kimia Biosciences Limited board meets on May 29, 2026, to consider audited financial results for FY26. Trading window remains closed until results declaration.

20 May 2026

companies

Kimia Biosciences Files Q4 FY26 SEBI Compliance Certificate

Kimia Biosciences Limited submitted its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026, confirming adherence to dematerialization norms.

15 Apr 2026

companies

Kimia Biosciences clarifies price movement query

Kimia Biosciences responds to BSE inquiry on price movement, stating no undisclosed information exists and movement is market-driven with full regulatory compliance maintained.

14 Apr 2026

companies

Kimia Biosciences Board Approves Key Management Changes

Kimia Biosciences appointed two new independent directors, a new Company Secretary, and reconstituted board committees following resignation of previous CS and cessation of an independent director.

04 Apr 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number